ProPharma Receives 2024 CRO Leadership Award [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Cybin Inc. Common Shares (CYBN)
Company Research
Source: Yahoo! Finance
June 13, 2024 /PRNewswire/ -- ProPharma , the world's largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award, presented by Clinical Leader . ProPharma is recognized as exceeding expectations in all five of the core categories, which include: Capabilities (Overall) Compatibility (Overall, Small Pharma) Expertise (Overall) Quality (Overall) Reliability (Overall, Small Pharma) The awards were developed to address struggles in efficiently vetting potential CRO partners. They are based on primary market research from Industry Standard Research (ISR) Reports and presented by Clinical Leader and Life Science Connect . In addition, sponsors provided ratings of CROs based on recent outsourced projects, and this experiential feedback is analyzed by sponsor company size to reveal leading CROs in different performance categor
Show less
Read more
Impact Snapshot
Event Time:
CYBN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYBN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYBN alerts
High impacting Cybin Inc. Common Shares news events
Weekly update
A roundup of the hottest topics
CYBN
News
- What Makes Cybin Inc. (CYBN) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Cybin Reports Fiscal Year 2024 Financial Results and Recent Business HighlightsBusiness Wire
- Cybin Inc. (NYSE: CYBN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference [Yahoo! Finance]Yahoo! Finance
CYBN
Earnings
- 6/26/24 - Miss
CYBN
Sec Filings
- 6/27/24 - Form 6-K/A
- 6/26/24 - Form 6-K
- 6/26/24 - Form 40-F
- CYBN's page on the SEC website